Bioregenx (BRGX) Net Income towards Common Stockholders Growth (1y) (2023 - 2026)

Bioregenx (BRGX) Net Income towards Common Stockholders Growth (1y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn 14.35%
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn 275.50%
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn 28.75%
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn -71.96%
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn -69.40%
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn 60.80%
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn 48.00%
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn -38.64%
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn 262.39%
10 Bioregenx - - 348,288.00 52.46%

Historic Data

Download Data
DateValue
Mar 31, 2026 52.46%
Dec 31, 2025 94.47%
Sep 30, 2025 79.60%
Jun 30, 2025 83.88%
Mar 31, 2025 62.14%
Dec 31, 2024 -2,455.76%
Sep 30, 2024 -10,597.91%
Jun 30, 2024 -26,695.74%
Mar 31, 2024 -206.65%
Dec 31, 2023 -12,907.52%
Sep 30, 2023 -68.46%
Jun 30, 2023 87.59%
Mar 31, 2023 -515.87%